Journal of Adolescent Health
Volume 21, Issue 3 , Pages 143-146, September 1997

Counseling sexually active teenagers treated with potential human teratogens

    MD
  • Kathleen Shilalukey

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Miriam Kaufman

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Susan Bradley

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • William H. Francombe

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Koffi Amankwah

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Eudice Goldberg

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Neil Shear

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Nancy F. Olivieri

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • , MD
  • Gideon Koren

      Affiliations

    • Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hematology, Adolescent Medicine, the Hospital for Sick Children, Canada
    • Toronto Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
    • Corresponding Author InformationAddress reprint requests to: Gideon Koren, M.D., Division of Clinical Pharmacology, Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada.

Accepted 13 December 1996.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1054-139X(97)00041-4

doi:10.1016/S1054-139X(97)00041-4

Journal of Adolescent Health
Volume 21, Issue 3 , Pages 143-146, September 1997